Cytokinetics Inc (CYTK)
Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms
Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms
Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference
Bristol Myers Squibb - Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
Did You Lose Money in Perrigo Company? PRGO Stockholders Should Contact Robbins LLP for Information About Their Rights Against PRGO.
Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans
Novartis and US government reach agreement on lowering drug prices in the US
Gilead - Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans